VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
104 hedge funds and large institutions have $380M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 102 → 104 (+2)
9% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 22
Holders
104
Holding in Top 10
2
Calls
$35.7M
Puts
$25.5M
Top Buyers
| 1 | +$22.7M | |
| 2 | +$19.4M | |
| 3 | +$9.43M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$8.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.44M |
Top Sellers
| 1 | -$6.98M | |
| 2 | -$4.37M | |
| 3 | -$3.86M | |
| 4 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$3.41M |
| 5 |
VAM
Visium Asset Management
New York
|
-$3.09M |